Inactive Instrument

GenMark Diagnostics, Inc.

Equities

GNMK

US3723091043

Advanced Medical Equipment & Technology

Genmark Diagnostics, Inc. Provides Revenue Guidance for the Full Year 2020

March 01, 2020

GenMark Diagnostics, Inc. provided revenue guidance for the full year 2020. The company expects revenue for the full year 2020 in the range of $100 million to $110 million, which represents growth of 14% to 25%, updated from 20-25% previously communicated.

Latest news about GenMark Diagnostics, Inc.

GenMark Diagnostics, Inc. Announces Executive Changes	21-04-22	CI
Roche : Secures 83% Acceptances In $1.8 Billion Tender Offer For GenMark Diagnostics	21-04-22	MT
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Global BMI Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P TMI Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Healthcare Equipment Select Industry Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Completeness Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Comp Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth-Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth-Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from NASDAQ Composite Index	21-04-22	CI
Roche Holding AG completed the acquisition of GenMark Diagnostics, Inc..	21-04-20	CI
Insider Trends: GenMark Diagnostics Insider Exercises Options Extending 90-Day Buying Trend	21-04-16	MT
Roche : U.S. lab products provider Avantor to buy Germany's Ritter for $1.1 bln	21-04-12	RE

Chart GenMark Diagnostics, Inc.

Duration

Period

More charts

Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+9.48%	222B
DANAHER CORPORATION	+13.72%	195B
INTUITIVE SURGICAL, INC.	+23.79%	148B
BOSTON SCIENTIFIC CORPORATION	+33.39%	113B
SIEMENS HEALTHINEERS AG	+4.75%	66.45B
EDWARDS LIFESCIENCES CORPORATION	+15.59%	53.11B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.16%	50.03B
AGILENT TECHNOLOGIES, INC.	-4.35%	38.8B
GE HEALTHCARE TECHNOLOGIES INC.	-1.27%	34.85B

Other Advanced Medical Equipment & Technology